Atridia Pty Ltd.
Clinical trials sponsored by Atridia Pty Ltd., explained in plain language.
-
New obesity drug HRS-5817 enters early human testing
Disease control OngoingThis early-phase study tests a single injection of HRS-5817 in 40 obese adults aged 18-55 with a BMI of 30-40. The main goal is to check safety and side effects, not to cure obesity. Researchers will also measure how the drug moves through the body and how the immune system respo…
Phase: EARLY_PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated May 18, 2026 12:06 UTC
-
New psoriasis drug candidate begins first human safety tests
Knowledge-focused OngoingThis early-stage study is testing a single dose of a new drug called SHR-1139 in 24 healthy adults. The main goal is to see if it is safe and how the body processes it. This is a first step toward possibly treating psoriasis, but no patients with the condition are involved yet.
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC